4 days ago
Experts convene in Qatar to enhance lymphoma patient care
Tribune News Network
Doha
Roche Pharmaceuticals, through its local representative Ebn Sina Medical, a fully owned subsidiary of Aamal Company Q.P.S.C., convened a significant workshop dedicated to the advancements in lymphoma treatment, specifically targeting Diffuse Large B-Cell Lymphoma (DLBCL). This high-profile event, known as the Redefining Lymphoma Gulf Countries Annual Forum, served as a platform for knowledge exchange and collaborative discussion among leading hematology experts.
Thirteen distinguished professionals, representing Qatar, Kuwait, Oman, Egypt, and the United Kingdom, participated in this intensive forum.
The agenda centered on the most current updates in the clinical management pathways for DLBCL, a challenging hematological malignancy. Beyond the presentation of cutting-edge research and therapeutic strategies, the workshop facilitated an invaluable opportunity for these experts to share their firsthand experiences in treating DLBCL patients.
They delved into real-world treatment outcomes observed in their respective national healthcare systems, providing a rich tapestry of practical insights that complemented the theoretical advancements Honar Cherif, head of NCCCR in Qatar, remarked, 'Organising such events is crucial for fostering collaboration and continuous medical education.
Pharmaceutical companies' role in facilitating these workshops is invaluable as it brings together experts who can exchange knowledge and advance patient care in hematology.'Dr. Wendy Osborne, Consultant Haematologist specialising in Lymphoma at Freeman Hospital, Newcastle, emphasised, 'Sharing experiences and getting exposed to different practices across the world are fundamental to improving patient outcomes.
I am highly appreciative of the quality of care in the region, and forums like these are essential for pushing the boundaries of lymphoma treatment and care.'
Omar Hamdy, Roche Qatar and Oman Lead, stated, 'Roche is proud to organize The Redefining Lymphoma Gulf Forum, an event that drives hematology innovation.
This forum enables Gulf healthcare professionals to share their experiences to improve patient care and create long-term lymphoma treatment strategies, aligning with Roche's core purpose.'
As part of Aamal Company's continued commitment to supporting Qatar's healthcare sector, Ebn Sina Medical remains focused on enhancing patient access to innovative treatments through strategic partnerships with leading global pharmaceutical companies.
